Use of a metabolomic approach to non-invasively diagnose non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus.

Fernando BrilLaura MillánSrilaxmi KalavalapalliMichael J McPhaulMichael P CaulfieldIbon Martinez-ArranzCristina AlonsoPablo Ortiz BetesJosé M MatoKenneth Cusi

Published in: Diabetes, obesity & metabolism (2018)

There is a great need to develop non-invasive approaches to diagnose non-alcoholic steatohepatitis in patients with T2DM; models originally developed for patients without diabetes cannot be directly applied to patients with T2DM.

Keyphrases

end stage renal disease
type diabetes
newly diagnosed
ejection fraction
glycemic control
chronic kidney disease
peritoneal dialysis
prognostic factors
liver fibrosis
liver injury
patient reported outcomes
skeletal muscle
insulin resistance
drug induced